PMC:7571312 / 20195-20371 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T333","span":{"begin":74,"end":83},"obj":"Chemical"},{"id":"T334","span":{"begin":135,"end":137},"obj":"Chemical"}],"attributes":[{"id":"A333","pred":"chebi_id","subj":"T333","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A334","pred":"chebi_id","subj":"T334","obj":"http://purl.obolibrary.org/obo/CHEBI_74327"}],"text":"Evaluation of the pharmacokinetic profile of 3 in rat suggested that this inhibitor possessed properties potentially sufficient for an IV continuous infusion dosing paradigm.42"}

{"project":"LitCovid-sentences","denotations":[{"id":"T128","span":{"begin":0,"end":176},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Evaluation of the pharmacokinetic profile of 3 in rat suggested that this inhibitor possessed properties potentially sufficient for an IV continuous infusion dosing paradigm.42"}

{"project":"LitCovid-PubTator","denotations":[{"id":"528","span":{"begin":50,"end":53},"obj":"Species"}],"attributes":[{"id":"A528","pred":"tao:has_database_id","subj":"528","obj":"Tax:10116"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Evaluation of the pharmacokinetic profile of 3 in rat suggested that this inhibitor possessed properties potentially sufficient for an IV continuous infusion dosing paradigm.42"}